The ideal home hemodialysis machine

Hemodialysis International

Volumn 12, Issue SUPPL. 1, 2008, Pages

  Kjellstrand, Carl M ^a,b,c,f   Kjellstrand, Per ^d,e  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e Gambro AB   (Sweden)

^f FACP   (United States)

Author keywords

Daily hemodialysis; Hemodiafiltration; Home hemodialysis; Ultrapure

Indexed keywords

ANTICOAGULATION; ARTICLE; ARTIFICIAL KIDNEY; BIOMEDICAL TECHNOLOGY ASSESSMENT; DIALYSATE; DIALYSIS CATHETER; DIALYSIS EQUIPMENT AND SUPPLIES; HEMODIAFILTRATION; HOME DIALYSIS; MAN MACHINE INTERACTION; PATIENT SATISFACTION; SURVIVAL RATE; TREATMENT DURATION;

EQUIPMENT DESIGN; HEMODIAFILTRATION; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 47649124552     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00293.x     Document Type: Article

References (29)

1. U.S. Renal Data System (USRDS). Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2005.
2. Canadian Organ Replacement Register. 1993 Annual Report. Canadian Institute for Health Information, Don Mills, ON, March 1995; 205-207.
3. Woods J, Port F, Stannard D, Blagg C, Held P. Comparison of mortality with home hemodialysis and center hemodialysis: A national study. Kidney Int. 1996; 49:1464-1470.
4. Kjellstrand C, Buoncristiani U, Ting G, et al. Short daily hemodialysis: Survival in 415 patients treated for 1006 patient years. Nephrol Dial Transplant. 2008 [Epub ahead of print].
5. Saner E, Nitsch D, Descoudres C, Frey F, Uehlinger D. Outcome of home hemodialysis patients: A case cohort study. Nephrol Dial Transplant. 2005; 20:1630-1637.
6. McGregor D, Buttimore A, Robson R, Little P, Morton J, Lynn K. Thirty years of universal home dialysis in Christchurch. NZ Med J. 2000; 113:27-29.
7. Blagg CR, Kjellstrand CM, Ting G, Young B. Comparison of survival between short-daily hemodialysis and conventional hemodialysis using the standardized mortality ratio. Hemodial Int. 2006; 10:371-374.
8. Kjellstrand C, Kjellstrand P. Beyond ultrapure hemodialysis - A desirable and reachable goal. Hemodial Int. 2007; 11(Suppl 1):S39-S48.
9. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998; 53:1399-1404.
10. Kjellstrand CM, Odar-Cederlof I, Ing TS, Blagg CR. Studies of phosphate dynamics during hemodialysis. Hemodial Int. 2005; 9:100.
11. Kooienga L. Phosphorus balance with daily dialysis. Semin Dial. 2007; 20:342-345.
12. Mohr P, Neumann P, Franco S, Marainen J, Lockridge R, Ting G. The case for daily dialysis: Its impact on costs and quality of life. Am J Kidney Dis. 2001; 37:777-789.
13. Heidenheim AP, Muirhead N, Moist L, Lindsay RM. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis. 2003; 42(Suppl 1):S36-S40.
14. Saito A, Gejyo F. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients. Ther Apher Dial. 2006; 10:316-320.
15. Lonnemann G. The quality of dialysate: An integrated approach. Kidney Int. 2000; 76(Suppl): S112-S119.
16. Kjellstrand CM, Kjellstrand P, Odar-Cederlof I, Blagg CR, Ing TS. Studies of beta-2 microglobulin dynamics during hemodialysis. Hemodial Int. 2006; 10:127.
17. Kjellstrand CM, Blagg CR, Twardowski Z, Bower J. Approaches to quotidian dialysis: The Aksys personal hemodialysis system. Semin Dial. 2004; 17:151-153.
18. Tsuchida K, Takemoto Y, Yamagami S, et al. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods. Nephron. 1997; 75:438-443.
19. Schindler R, Beck W, Deppisch R, et al. Short bacterial DNA fragments: Detection in dialysate and induction of cytokines. J Am Soc Nephrol. 2004; 15:3207-3214.
20. Lavaud S, Paris B, Maheut H, et al. Assessment of the heparin-binding AN69 ST hemodialysis membrane: II. Clinical studies without heparin administration. ASAIO J. 2005; 51:348-351.
21. Ing TS, Cheng YL, Tsang KY, et al. Combined use of citrate-enriched dialysis solution and heparinized saline-rinsed dialyzer for hemodialysis. Hemodial Int. 2008; 12:122-123.
22. Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: The relief for acutely fluid-overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial. J Am Coll Cardiol. 2005; 46:2043-2046.
23. Miwa M, Shinzato T. Push/pull hemodiafiltration: Technical aspects and clinical effectiveness. Artif Organs. 1999; 23:1123-1126.
24. Shinzato T, Maeda K. Push/pull hemodiafiltration. Contrib Nephrol. 2007; 158:169-176.
25. Nakai S, Iseki K, Tabei K, et al. Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis. 2001; 38(Suppl 1):S212-S216.
26. Kjellstrand CM, Blagg CR, Twardowski Z, Bower J. Blood access and daily hemodialysis: Clinical experience and review of the literature. ASAIO J. 2003; 49:645-649.
27. Alwall N. Historical perspective on the development of the artificial kidney. Artif Organs. 1986; 10:86-99.
28. Pollard TL, Barnett BMS, Eschbach JW, Scribner BH. A technique for storage and multiple re-use of the Kiil dialyzer and blood tubing. Trans Am Soc Artif Intern Organs. 1967; 13:24-28.
29. Twardowski ZJ. Dialyzer reuse - Part I: Historical perspective. Semin Dial. 2006; 19: 41-53.